Injection of ApoAI into mice [48] and rabbits [49] has also been documented, indicating that increasing the level of available ApoAI may be much simpler than other lipid-altering mechanisms, which shows promise as the disease burden of atherosclerosis continues to rise around the world [8]. Here, APOA1 is linked to atherosclerosis.